---
document_datetime: 2023-09-21 20:25:17
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ontozry-epar-all-authorised-presentations_en.pdf
document_name: ontozry-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.6386927
conversion_datetime: 2025-12-30 00:41:51.972203
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength        | Pharmaceutical Form         | Route of Administration   | Immediate Packaging   | Pack size                                               |
|------------------|-------------------|-----------------|-----------------------------|---------------------------|-----------------------|---------------------------------------------------------|
| EU/1/21/1530/001 | Ontozry           | 25 mg + 12.5 mg | Film-coated tablet + tablet | Oral use                  | blister (PVC/alu)     | Initiation pack: 28 tablets (14 x 25 mg + 14 x 12.5 mg) |
| EU/1/21/1530/002 | Ontozry           | 50 mg           | Film-coated tablet          | Oral use                  | blister (PVC/alu)     | 14 tablets                                              |
| EU/1/21/1530/003 | Ontozry           | 50 mg           | Film-coated tablet          | Oral use                  | blister (PVC/alu)     | 28 tablets                                              |
| EU/1/21/1530/004 | Ontozry           | 50 mg           | Film-coated tablet          | Oral use                  | blister (PVC/alu)     | 84 tablets                                              |
| EU/1/21/1530/005 | Ontozry           | 100 mg          | Film-coated tablet          | Oral use                  | blister (PVC/alu)     | 14 tablets                                              |
| EU/1/21/1530/006 | Ontozry           | 100 mg          | Film-coated tablet          | Oral use                  | blister (PVC/alu)     | 28 tablets                                              |
| EU/1/21/1530/007 | Ontozry           | 100 mg          | Film-coated tablet          | Oral use                  | blister (PVC/alu)     | 84 tablets                                              |
| EU/1/21/1530/008 | Ontozry           | 150 mg          | Film-coated tablet          | Oral use                  | blister (PVC/alu)     | 14 tablets                                              |
| EU/1/21/1530/009 | Ontozry           | 150 mg          | Film-coated tablet          | Oral use                  | blister (PVC/alu)     | 28 tablets                                              |
| EU/1/21/1530/010 | Ontozry           | 150 mg          | Film-coated tablet          | Oral use                  | blister (PVC/alu)     | 84 tablets                                              |
| EU/1/21/1530/011 | Ontozry           | 200 mg          | Film-coated tablet          | Oral use                  | blister (PVC/alu)     | 14 tablets                                              |
| EU/1/21/1530/012 | Ontozry           | 200 mg          | Film-coated tablet          | Oral use                  | blister (PVC/alu)     | 28 tablets                                              |
| EU/1/21/1530/013 | Ontozry           | 200 mg          | Film-coated tablet          | Oral use                  | blister (PVC/alu)     | 84 tablets                                              |